About IMCannabis
IMCannabis is a company based in Herzliya (Israel) founded in 2008. The company has 55 employees. IMCannabis has completed 2 acquisitions, including Highland Grow and MYM Nutraceuticals. IMCannabis operates in a competitive market with competitors including ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.
- Headquarter Herzliya, Israel
- Employees 55
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website imcannabis.com
- Social Facebook
- Legal Name Im Cannabis Corp.
- Annual Revenue$39.17 M (USD)-0.69as on Dec 31, 2025
- Net Profit-$8.1 M (USD)-4.84as on Dec 31, 2025
- EBITDA-$2.32 M (USD)34.03as on Dec 31, 2025
- Latest Funding Round$1.54M (USD), Post-IPO
Nov 2024
- Employee Count55
- Investments & AcquisitionsHighland Grow
& 1 more
Funding Insights of IMCannabis
- Total Rounds 5
- Last Round Post-IPO — $1.54M
- First Round $313,604
(Jun 2020)
- Investors Count 1
All 5 funding rounds of IMCannabis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $1.54M | Post-IPO | – | – | – |
| Jan 2023 | $950,562 | Post-IPO | – | – | – |
| Oct 2022 | $556,252 | Post-IPO | – | – | – |
| Aug 2022 | $2.44M | Post-IPO | – | – | |
| Jun 2020 | $313,604 | Post-IPO | – | – | – |
1 investors in total: 0 institutional and 1 angel.
Investors in IMCannabis
IMCannabis has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Marc Lustig.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
ML Marc Lustig | Angel investor and entrepreneur, focused on tech startups in India. | – | unknown_c815777d320d4dab9 | - |
Investor details for IMCannabis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of IMCannabis
7 people are tracked at IMCannabis (5 in leadership, 2 in team); the tracked headcount is 55.
| Name | Role | Group |
|---|---|---|
Oren Shuster | CEO | Leadership |
Anna Taranko | Director Of Marketing And Investor Relations | Leadership |
Ziv M. | Head Of Operations | Leadership |
Shai Shemesh | CFO | Leadership |
Yael Harrosh | Chief Legal & Operations Officer | Leadership |
michal lebovitz | General Counsel | Team |
Ruth Shapira | Digital Marketing Specialist | Team |
Complete people profiles for IMCannabis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of IMCannabis
IMCannabis is a publicly listed company on the NASDAQ with ticker symbol IMCC in USA, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Nov 2019
- Listed onCSE: IMCC
- Listed entityIM Cannabis Corp.
- Exchange sectorProcess industries
- ISINCA44969Q5059
- Share price$1.58 (-8.14% on the day) · 2026-10-09
- Market capitalisation$2.6M
- EPS (diluted, trailing year)$-62.81
- Volume (last session)154,453
Financials of IMCannabis
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $39.2M | -$8.1M | -$2.3M |
| 2024 | $39.4M | -$7.7M | -$3.5M |
| 2023 | $36.2M | -$7.0M | -$6.8M |
| 2022 | $41.7M | -$145.1M | -$14.4M |
| 2021 | $27.2M | -$14.2M | -$18.8M |
Detailed financial statements for IMCannabis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IMCannabis
IMCannabis has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Highland Grow and MYM Nutraceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cannabis products are manufactured by Highland Grow in Canada. | highlandgrow.com | Antigonish, Canada | 2018 | Apr 2021 | •••• | |
Design-build services for cannabis cultivation facilities are provided. | mym.ca | Vancouver, Canada | 2014 | Apr 2021 | •••• |
Complete acquisition details for IMCannabis
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of IMCannabis
6 dated milestones of IMCannabis across 16 years, from founding to its latest funding, stage changes and deals.
- Founded IMCannabis is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $314K.
- Acquisition Acquires MYM Nutraceuticals.
- Acquisition Acquires Highland Grow.
- Funding Latest funding round, Post-IPO, of $1.5M.
Competitors of IMCannabis
IMCannabis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zyus.com | 2018 | Saskatoon, Canada | $19.5M | – | Cannabis-derived therapeutics for multiple indications are developed. | |
| sanitygroup.com | 2011 | Berlin, Germany | $108.79M | – | Developer of cannabinoid-based pharmaceuticals and well-being products | |
| terraflos.com | 2021 | Uruguay | $8M | – | Medical cannabis products are provided based on GMP processes. | |
| avicanna.com | 2016 | Toronto, Canada | $5.94M | – | Plant-derived cannabinoid products are developed for medical and consumer uses. | |
| littlegreenpharma.com | 2016 | Perth, Australia | $1.91M | – | Manufacturer of medicinal cannabis for therapeutic use | |
| neocannbio.com | 2021 | Seoul, South Korea | $10.9M | – | Cannabinoid-based pharmaceuticals and production technologies are developed. | |
| gleaf.com | 2014 | Frederick, United States | $19.45M | 230 | Medical cannabis is cultivated by gLeaf for dispensary supply. |
Detailed competitors of IMCannabis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of IMCannabis
The website of IMCannabis (imcannabis.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 1.9% vs previous month
Websites whose visitors overlap most with IMCannabis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
retorno.org.il | retorno.org.il | 100% | – | #2,724,840 | – |
Latest news on Imcannabis
Complete news archive for IMCannabis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to IMCannabis
10 companies that operate in the same segment as IMCannabis (Cannabis Health Tech Ecosystem), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cannabis products are provided to support consumer wellness and health. | 2013 | Smiths Falls, Ontario, Canada | – | USD 204.24 M | 960 | |
Online marketplace platform for cannabis traders | 2015 | New York, New York, United States | USD 195.4 M | – | – | |
Loyalty and marketing solutions for cannabis dispensaries are provided. | 2012 | West Palm Beach, Florida, United States | USD 25.79 M | USD 22.83 M | – | |
An online marketplace for cannabis products is operated. | 2017 | Bend, Oregon, United States | USD 603 M | – | 137 | |
Online platform for cannabis strains, reviews, and ratings | 2010 | Seattle, Washington, United States | USD 40.7 M | – | – | |
Provider of cannabis products, brands, and international business development investments | 2013 | Moncton, New Brunswick, Canada | – | USD 186.16 M | 898 | |
ERP software is offered via cloud platform for cannabis operations. | 2018 | Boston, Massachusetts, United States | – | USD 110.08 M | 313 | |
Online marketplace connecting licensed cannabis vendors and dispensaries | 2015 | Chicago, Illinois, United States | USD 22.57 M | – | – | |
Enterprise software is provided for cannabis dispensary management. | 2016 | Oakland, California, United States | USD 75.5 M | USD 148.97 K | 97 | |
Proprietary medical cannabis strains are developed and offered. | 2014 | Maryland Heights, Missouri, United States | USD 156 M | – | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IMCannabis
IMCannabis was founded in 2008 and raised its 1st funding round 12 years after it was founded.
IMCannabis is headquartered in Herzliya, Israel. It is registered at Herzliya, Central District, Israel.
Oren Shuster is the current CEO of IMCannabis.
IMCannabis has 55 employees.
Annual revenue of IMCannabis is $39.17M as on Dec 31, 2025.
Developer of medical cannabis productss. It has developed strains oils, and products for various diseases like oncology, PTSD, epilepsy, Crohns colitis, ALS, fibromyalgia, multiple sclerosis, Parkinsons, Tourette, chronic pain, eating disorder, and others.
IMCannabis's top competitors include Avicanna, ZYUS Life Sciences and Neocannbio.
Yes, IMCannabis is publicly traded on NASDAQ under the ticker symbol IMCC.
IMCannabis has made 2 acquisitions, including Highland Grow, and MYM Nutraceuticals.
IMCannabis has 1 investor. Key investors include Marc Lustig.